# US 2026/0198813 A1 · Oral devices with hydrogels for capture and detection of disease biomarkers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0198813 A1
- Document ID: US20260198813A1
- Status: Published application
- Kind: A1
- Application number: 19/336,211
- Filed: 2025-09-22
- Published: 2026-07-16
- Earliest claimed: 2025-01-15
- Assignees: Align Technology, Inc.
- Applicants: Align Technology, Inc.
- Inventors: Julie Coletti; Michael Austin Brown; Mitra Derakhshan; Allison Warren
- Web page: https://patentgrep.com/patent/US20260198813A1

## CPC

- A61B 5/0071: {by measuring fluorescence emission}
- A61B 5/1459: invasive, e.g. introduced into the body by a catheter
- A61B 5/0088: {for oral or dental tissue}
- A61B 5/14507: {specially adapted for measuring characteristics of body fluids other than blood (devices for taking samples of body liquids A61B10/0045)}
- A61B 5/4277: {saliva secretion}
- A61B 5/4552: {Evaluating soft tissue within the mouth, e.g. gums or tongue}
- A61B 5/682: {Mouth, e.g., oral cavity; tongue; Lips; Teeth}
- A61B 5/6847: {mounted on an invasive device}
- A61K 49/0017: {Fluorescence in vivo}
- A61K 49/0073: {semi-solid, gel, hydrogel, ointment}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Systems and methods for detecting a disease biomarker in a subject are provided. In some embodiments, a system includes: an oral device configured to be positioned within a subject's mouth; a hydrogel carried by the oral device, where the hydrogel includes a polymer and a capture moiety coupled to the polymer, and where the capture moiety is configured to bind to a disease biomarker present in the subject's mouth; and a fluorescent moiety configured to label the disease biomarker bound by the capture moiety.

## Claims

### Claim 1

A system for detecting a disease biomarker in a subject, the system comprising:
an oral device configured to be positioned within a subject's mouth;
a hydrogel carried by the oral device, wherein the hydrogel comprises a polymer and a capture moiety coupled to the polymer, and wherein the capture moiety is configured to bind to a disease biomarker present in a physiological fluid in the subject's mouth, and wherein the disease biomarker is a biomarker for oral cancer;
a fluorescent moiety configured to label the disease biomarker bound by the capture moiety;
an imaging device configured to obtain image data of the oral device and the hydrogel; and
one or more processors configured to perform operations comprising:
detecting whether the labeled disease biomarker is present in the image data, and
determining a diagnosis for the subject based on whether the labeled disease biomarker is present in the image data.

### Claim 2 (depends on 1)

The system of claim 1, wherein the oral device comprises a dental appliance.

### Claim 3 (depends on 2)

The system of claim 2, wherein the dental appliance is an aligner, a retainer, or a palatal expander.

### Claim 4 (depends on 2)

The system of claim 2, wherein the dental appliance comprises a shell having a plurality of teeth-receiving cavities, and wherein the hydrogel is coated onto a surface of the shell.

### Claim 5 (depends on 1)

The system of claim 1, wherein the oral device comprises a lollipop-type device having an intraoral portion coupled to a support shaft.

### Claim 6 (depends on 1)

The system of claim 1, wherein the polymer comprises agarose, alginate, cellulose, chitosan, collagen, dextran, fibrin, gelatin, guar gum, hyaluronic acid, keratin, pectin, silk, starch, poly(2-hydroxyethyl methacrylate), poly(acrylic acid), poly(caprolactone), poly(ethylene glycol), poly(glycolide), poly(lactic-co-glycolic acid), poly(lactide), poly(methacrylic acid), poly(N-isopropylacrylamide), poly(vinyl alcohol), polyacrylamide, polystyrene, polyurethane, polyvinylpyrrolidone, or a derivative or a combination thereof.

### Claim 7 (depends on 1)

The system of claim 1, wherein the capture moiety is covalently coupled to the polymer.

### Claim 8 (depends on 1)

The system of claim 1, wherein the capture moiety is configured to specifically bind to the disease biomarker.

### Claim 9 (depends on 1)

The system of claim 1, wherein the capture moiety is configured to bind to a plurality of species present in the subject's mouth.

### Claim 10 (depends on 1)

The system of claim 1, wherein the fluorescent moiety is configured to bind to the disease biomarker.

### Claim 11 (depends on 1)

The system of claim 1, wherein the disease biomarker is present in saliva.

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The system of claim 1, wherein the imaging device is an intraoral scanner.

### Claim 15

A method for detecting a disease biomarker in a subject, the method comprising:
positioning an oral device within a subject's mouth, wherein the oral device comprises a hydrogel including a polymer and a capture moiety coupled to the polymer;
binding a disease biomarker present in a physiological fluid in the subject's mouth with the capture moiety, wherein the disease biomarker is a biomarker for oral cancer;
labeling the disease biomarker bound by the capture moiety with a fluorescent moiety;
obtaining image data of the oral device including the hydrogel with the labeled disease biomarker using an imaging device;
detecting, via one or more processors, whether the labeled disease biomarker is present in the image data; and
determining, via the one or more processors, a diagnosis for the subject based on whether the labeled disease biomarker is present in the image data.

### Claim 16 (depends on 15)

The method of claim 15, wherein the oral device comprises a dental appliance.

### Claim 17 (depends on 16)

The method of claim 16, wherein the dental appliance is an aligner, a retainer, or a palatal expander.

### Claim 18 (depends on 16)

The method of claim 16, wherein the dental appliance comprises a shell having a plurality of teeth-receiving cavities, and wherein the hydrogel is coated onto a surface of the shell.

### Claim 19 (depends on 15)

The method of claim 15, wherein the oral device comprises a lollipop-type device having an intraoral portion coupled to a support shaft.

### Claim at position 20

20-28. (canceled)

### Claim 29 (depends on 15)

The method of claim 15, further comprising removing the oral device from the subject's mouth before labeling the disease biomarker and obtaining the image data.

### Claim 30

(canceled)

### Claim 31 (depends on 1)

The system of claim 1, wherein the imaging device is a mobile device.

### Claim 32 (depends on 1)

The system of claim 1, wherein the image data comprises a plurality of 2D images.

### Claim 33 (depends on 32)

The system of claim 32, wherein the plurality of 2D images comprise images obtained using different imaging modalities.

### Claim 34 (depends on 1)

The system of claim 1, wherein the operations further comprise identifying a location of a fluorescent signal corresponding to the fluorescent moiety in the image data.

### Claim 35 (depends on 34)

The system of claim 34, wherein the operations further comprise:
generating a digital representation of a geometry of the oral device, based on the image data, and
determining a spatial distribution of the fluorescent signal with respect to the geometry of the oral device.

### Claim 36 (depends on 34)

The system of claim 34, wherein determining the diagnosis comprises determining a location of the oral cancer in the subject's mouth, based on the identified location of the fluorescent signal.

### Claim 37 (depends on 36)

The system of claim 36, wherein determining the diagnosis comprises comparing the determined location of the oral cancer to a location identified from image data obtained using a different imaging modality.

### Claim 38 (depends on 1)

The system of claim 1, wherein determining the diagnosis comprises comparing the image data to previous image data.

### Claim 39 (depends on 38)

The system of claim 38, wherein the previous image data is obtained at a previous time point.

### Claim 40 (depends on 38)

The system of claim 38, wherein the previous image data depicts a second oral device that was previously positioned within the subject's mouth.

### Claim 41 (depends on 40)

The system of claim 40, wherein the second oral device includes the hydrogel comprising the polymer and the capture moiety coupled to the polymer.

### Claim 42 (depends on 38)

The system of claim 38, wherein the comparing comprises identifying a change in one or more of a presence, amount, or location of the labeled disease biomarker over time.
